Clinical Trial: A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in the Treatment of Children, Adolescents and Adults With Mild to Moderate Atopic Dermatitis
Brief Summary:
This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ?2 years of age with mild to moderate AD.The study will also evaluate the long-term efficacy of difamilast ointment 1%, including durability of response.
Read more